Writing in the journal British Medical Journal Case Reports, doctors at the Sir Charles Gairdner Hospital in Western ...
The study objective was to evaluate the association of proton pump inhibitors (PPIs) and community-acquired pneumonia (CAP). The design was a meta-analysis of nine case–controlled and cohort ...
Proton-pump inhibitors (PPIs) are the most effective medical therapy for patients with moderate-to-severe GERD and are widely prescribed to pregnant women. However, safety data about the use of ...
The global proton pump inhibitors (PPIs) market is currently valued at approximately USD 2.8 billion and is projected to grow ...
More than 54% of people in the United States who take heartburn medications called proton pump inhibitors (PPIs) daily still have acid reflux symptoms. Additionally, PPIs do not work for everyone.
Hosted on MSN1d
Doctors warn that common reflux drug could trigger SCURVYWriting in the journal British Medical Journal Case Reports, doctors at the Sir Charles Gairdner Hospital in Western ...
The following is a summary of “Brain Fog in Gastrointestinal Disorders: Small Intestinal Bacterial Overgrowth, Gastroparesis, ...
Phathom is in the final stages of obtaining FDA feedback on the Phase 2 study and program investigating VOQUEZNA as a potential treatment for Eosinophilic Esophagitis (EoE) in adults and adolescents, ...
Proton pump inhibitors (PPIs) are widely used medications to manage common digestive issues like heartburn, acid reflux, and ...
Melbourne-based law firm Shine Lawyers has launched a class action investigation into the health impacts from drugs known as proton pump inhibitors (PPI), with an estimated 100,000 Australians ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback